Skip to main content
Recall Canary
Memantine Hydrochloride Extended-Release 7 mg Capsules
← Back to all recalls
DRUG RECALLMODERATE

Memantine Hydrochloride Extended-Release 7 mg Capsules

Major Pharmaceuticals is recalling Memantine Hydrochloride Extended-Release 7 mg capsules (NDC 0904-6734-61) due to failed dissolution specifications.

What to do

Do not use this medication. Return the product to your pharmacy or contact Major Pharmaceuticals for instructions on obtaining a replacement or refund.

Posted
Updated
Recall No.
D-0485-2026
Agency
Firm
The Harvard Drug Group LLC
Recall ID
98672
Status
ONGOING

Why it was recalled

Failed Dissolution Specifications

How to identify it

Memantine Hydrochloride Extended-Release, Capsules, 7 mg, 100 Capsules (10 x 10 blister packs), Rx only, Packaged and Distributed by: Major Pharmaceuticals, Indianapolis, IN 46268, NDC 0904-6734-61

Where it was sold

Distributed in US.

Other recent recalls from The Harvard Drug Group LLC

← Back to all recalls

Editorial summary by Recall Canary · last updated 2026-04-27 · primary source: U.S. Food and Drug Administration · severity reflects the agency's published classification